Catatonia and Autoimmune Conditions in Children and Adolescents: Should We Consider a Therapeutic Challenge?

  • Vladimir Ferrafiat
  • , Marie Raffin
  • , Kumaran Deiva
  • , Xavier Salle-Collemiche
  • , Anne Lepine
  • , Michel Spodenkiewicz
  • , Isabelle Michelet
  • , Julien Haroche
  • , Zahir Amoura
  • , Priscille Gerardin
  • , David Cohen
  • , Angèle Consoli

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Abstract

Objective: Catatonia as a result of autoimmune conditions offers new therapeutic opportunities for patients that child and adolescent psychiatrists should consider. However, the diagnosis is sometimes challenging when an autoimmune signature is not identified. Methods: In this study, we aim to summarize seven cases from a 20-year series of 84 youths with catatonia, including three cases that represented a diagnostic challenge because of the absence of positive autoimmune testing. Results: Immunosuppressive/modulatory treatment improved catatonic and psychotic features in all cases. Conclusion: To facilitate treatment decision-making, we propose a causality assessment score and a treatment algorithm, which may help clinicians consider whether an autoimmune condition is associated with catatonia.

Original languageEnglish
Pages (from-to)167-176
Number of pages10
JournalJournal of Child and Adolescent Psychopharmacology
Volume27
Issue number2
DOIs
StatePublished - Mar 2017
Externally publishedYes

Keywords

  • Acute psychotic episode
  • Autoimmune condition
  • Catatonia
  • Immunosuppressive treatment
  • Treatment algorithm

Fingerprint

Dive into the research topics of 'Catatonia and Autoimmune Conditions in Children and Adolescents: Should We Consider a Therapeutic Challenge?'. Together they form a unique fingerprint.

Cite this